Access cutting-edge chronic spontaneous urticaria treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Scottsdale location
Access chronic spontaneous urticaria specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic spontaneous urticaria treatment provided free
Check if you qualify for this chronic spontaneous urticaria clinical trial in Scottsdale, AZ
No-Cost Study Care
Local to Scottsdale
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3b study to evaluate efficacy of remibrutinib (25 mg twice daily \[b.i.d.\] by mouth \[p.o.\]) compared to dupilumab (600 mg loading dose administered subcutaneously (s.c.) followed by 300 mg every 2 weeks s.c.) at early timepoints (4 weeks and earlier), when administered as an add-on treatment to second generation H1-antihistamines (sgH1-AH) (standard label dose as background therapy) in adult US participants with moderat
Sponsor: Novartis Pharmaceuticals
Yes, this clinical trial (NCT06868212) has an active research site in Scottsdale, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic spontaneous urticaria treatment options in Scottsdale, AZ, this clinical trial (NCT06868212) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic spontaneous urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic spontaneous urticaria clinical trials near you to find additional studies recruiting in your area.
See all chronic urticaria clinical trials recruiting in Scottsdale — not just this study.
Browse Chronic Urticaria Trials in Scottsdale →